|
FKBP8 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.91140003824586E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.63810000031984E-07 |
| Normal-vs-Stage2 |
7.19209999999748E-07 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
1.405800E-04 |
| Stage1-vs-Stage2 |
9.629000E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
4.955000E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
3.045800E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.88130003084564E-09 |
| Normal-vs-AfricanAmerican |
2.223400E-04 |
| Normal-vs-Asian |
9.60740000000015E-05 |
| Caucasian-vs-AfricanAmerican |
7.912200E-01 |
| Caucasian-vs-Asian |
9.627600E-01 |
| AfricanAmerican-vs-Asian |
6.971000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.14579999999942E-05 |
| Normal-vs-Female |
1.83000004039258E-09 |
| Male-vs-Female |
8.127400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.827100E-04 |
| Normal-vs-Extreme_Weight |
5.52329999514711E-08 |
| Normal-vs-Obese |
9.743600E-03 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
9.570800E-01 |
| Normal_Weight-vs-Obese |
8.999600E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
9.144200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.557770E-03 |
| Normal-vs-Age(41-60Yrs) |
1.96210000025232E-07 |
| Normal-vs-Age(61-80Yrs) |
5.8722999995986E-07 |
| Normal-vs-Age(81-100Yrs) |
3.164400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.973200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.994200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.823000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.577400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.619000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.912800E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
6.938400E-01 |
| Normal-vs-Grade 3 |
9.252200E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
5.235600E-01 |
| Grade 2-vs-Grade 4 |
6.938400E-01 |
| Grade 3-vs-Grade 4 |
9.252200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.4975000128814E-09 |
| Normal-vs-N1 |
1.245900E-04 |
| N0-vs-N1 |
5.194800E-01 |
|
|
